BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 29928436)

  • 1. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios may aid in identifying patients with non-small cell lung cancer and predicting Tumor-Node-Metastasis stages.
    Xu F; Xu P; Cui W; Gong W; Wei Y; Liu B; Dong J
    Oncol Lett; 2018 Jul; 16(1):483-490. PubMed ID: 29928436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the Inflammatory Cell Ratio NLR and PLR be Used as a Reliable Marker in Colon Cancer? A Prospective Study.
    Ramesh SK; Swain SK; Munikrishnan V; Jameel JKA
    Euroasian J Hepatogastroenterol; 2023; 13(2):61-65. PubMed ID: 38222963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of the platelet-to-lymphocyte ratio and fibrinogen may predict 5-year overall survival of patient in non-small cell lung cancer treated with surgery.
    Luo Y; Lin K; Zhang M; Goto T; Brueckl WM; Lin J; Liu X; Weng J; Ye Y
    J Thorac Dis; 2023 Dec; 15(12):6967-6975. PubMed ID: 38249876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative platelet-lymphocyte ratio and neutrophil-lymphocyte ratio as predictors of occult lymph node metastasis detected using Desmoglein 3 and Cytokeratin in Indian population.
    Urs AB; Augustine J; Khurana N; Uniyal A; Passey JC; Meher R
    J Oral Maxillofac Pathol; 2022; 26(4):596. PubMed ID: 37082044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining Classic and Novel Neutrophil-Related Biomarkers to Identify Non-Small-Cell Lung Cancer.
    Ren Y; Wang Q; Xu C; Guo Q; Dai R; Xu X; Zhang Y; Wu M; Wu X; Tu H
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-Lymphocyte Ratio and Risk of Nodal Metastasis in Early-Stage Lung Adenocarcinoma: A Brief Report From a Multicentric Analysis.
    Gallina FT; Chiappetta M; Tajè R; Forcella D; Sassorossi C; Congedo MT; Evangelista J; Sperduti I; Lococo F; Cappuzzo F; Melis E; Margaritora S; Facciolo F
    Clin Lung Cancer; 2024 Jun; 25(4):e196-e200.e1. PubMed ID: 38627156
    [No Abstract]   [Full Text] [Related]  

  • 7. Baicalein Inhibits Orthotopic Human Non-Small Cell Lung Cancer Xenografts via Src/Id1 Pathway.
    Zhao Z; Liu B; Sun J; Lu L; Liu L; Qiu J; Li Q; Yan C; Jiang S; Mohammadtursun N; Ma W; Li M; Dong J; Gong W
    Evid Based Complement Alternat Med; 2019; 2019():9806062. PubMed ID: 30949224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
    Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ
    J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Distinguishing Lung Cancer in People with HIV.
    Baluku JB; Namiiro S; Namanda B; Nabwana M; Andia-Biraro I; Worodria W; Salata R; Mfinanga S; Gerson S; Kirenga B
    Dis Markers; 2024; 2024():8822024. PubMed ID: 38292339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of adenocarcinoma subtypes and immunohistochemistry in predicting lymph node metastasis in early invasive lung adenocarcinoma.
    Xue M; Liu J; Li Z; Lu M; Zhang H; Liu W; Tian H
    BMC Cancer; 2024 Jan; 24(1):139. PubMed ID: 38287300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Inflammation and Nutrition-Based Scores in Non-Small Cell Lung Cancer.
    Erciyestepe M; Selvi O; Dinç Sonuşen Ş; Öztürk AE; Dinç G; Güneş TK; Aydın O; Yaşar N; Balkaya Aykut G; Vatansever S
    Med Princ Pract; 2024; 33(2):122-132. PubMed ID: 38091965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel potential drugs and miRNAs biomarkers in lung cancer based on gene co-expression network analysis.
    Hajipour S; Hosseini SM; Irani S; Tavallaie M
    Genomics Inform; 2023 Sep; 21(3):e38. PubMed ID: 37813634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role and research progress of hematological markers in laryngeal squamous cell carcinoma.
    Qi H
    Diagn Pathol; 2023 Apr; 18(1):50. PubMed ID: 37081512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray data analysis to identify miRNA biomarkers and construct the lncRNA-miRNA-mRNA network in lung adenocarcinoma.
    Song Y; Kelava L; Zhang L; Kiss I
    Medicine (Baltimore); 2022 Sep; 101(36):e30393. PubMed ID: 36086747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of selected platelet parameters of patients operated for non-small cell lung cancer.
    Łochowski M; Rębowski M; Chałubińska-Fendler J; Zawadzka I; Łochowska B; Cieślik-Wolski B; Kozak J
    J Thorac Dis; 2022 May; 14(5):1374-1383. PubMed ID: 35693601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative Predictive Models of Computed Tomography Texture Parameters and Hematological Parameters for Lymph Node Metastasis in Lung Adenocarcinomas.
    Chen W; Xu M; Sun Y; Ji C; Chen L; Liu S; Zhou K; Zhou Z
    J Comput Assist Tomogr; 2022 Mar-Apr 01; 46(2):315-324. PubMed ID: 35297587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDL-1 Expression and Survival in Metastatic Non-small Cell Lung Cancer Patients Who Received Chemotherapy as First-Line Treatment.
    Gursoy P; Çakar B; Gunenc D; Nart D; Çınkooğlu A; Katgı N
    Turk Thorac J; 2022 Jan; 23(1):45-51. PubMed ID: 35110200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Prognostic Significance of Preoperative Platelet-to-Lymphocyte and Neutrophil-to-Lymphocyte Ratios in Patients Operated for Non-Small Cell Lung Cancer.
    Łochowski M; Chałubińska-Fendler J; Zawadzka I; Łochowska B; Rębowski M; Brzeziński D; Kozak J
    Cancer Manag Res; 2021; 13():7795-7802. PubMed ID: 34675674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Factors Determining Survival of Patients Operated for Non-Small Cell Lung Cancer with Consideration Given to Morphological Parameters of Blood.
    Łochowski M; Łochowska B; Chałubińska-Fendler J; Zawadzka I; Rębowski M; Kozak J
    Cancer Manag Res; 2021; 13():479-487. PubMed ID: 33500661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune-inflammation index (SII): A More Promising Inflammation-Based Prognostic Marker for Patients with synchronic colorectal peritoneal carcinomatosis.
    Yan Q; Ertao Z; Zhimei Z; Weigang D; Jianjun P; Jianhui C; Chuangqi C
    J Cancer; 2020; 11(18):5264-5272. PubMed ID: 32742472
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.